Funded Projects › HORIZON
LATE-AYA · Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach
AYAs face a distinct set of challenges, including increased risks of secondary cancers, cardiovascular diseases, infertility, and mental health issues like anxiety and depression. Oncology programs delivering care to AYAs provide survivors with individualised survivorship care plans at the end of treatment, to accompany follow-up with their primary care providers. However, adherence to these plans is often scarce, due to differences in AYA survivors' age, sex, cancer treatment received, and socioeconomical conditions. Knowledge and understanding of such factors and of related late effects and impacts on quality of life is fundamental to providing effective survivorship care. The ubiquitous use of mobile devices by AYAs offers an opportunity to increase knowledge and understanding of AYAs cancer survivors’ health status and behaviours, allowing the modelling of late effects and quality of life trajectories in the different age subgroups. Digital health interventions overcome many barriers to AYA participation in survivorship programs. LATE-AYA seeks to fill this gap by empowering AYAs to better manage their health and well-being post-cancer, by developing an AI-driven digital phenotyping platform for managing late effects (LE) of cancer treatment. The project will implement a holistic, non-invasive approach through digital tools such as smartphones and wearables to monitor physical, psychological, and social well-being. The project will focus on preventive health behaviours, psychological support, and social reintegration, providing personalized care through digital interventions. LATE-AYA will contribute to long-term quality of life improvements, facilitate early detection of LE, and provide data-driven insights on the impact of lifestyle choices on health outcomes.This project is supported by a diverse consortium of European institutions and will leverage the UNCAN.eu platform to share data and models, fostering wider collaboration across the EU. This action is part of the Cancer Mission cluster of projects on “Quality of life (AYA)”.
Consortium · 21 organisations
UNIVERSIDAD POLITECNICA DE MADRID
ES · €746,250
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO)
ES · €398,750
FUNDACIO PRIVADA PER A LA RECERCA I LA DOCENCIA SANT JOAN DE DEU
ES · €231,875
ISTITUTO EUROPEO DI ONCOLOGIA SRL
IT · €315,000
FONDAZIONE CENTRO NAZIONALE DI ADROTERAPIA ONCOLOGICA
IT · €170,625
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS
EL · €360,625
NACIONALINIS VEZIO INSTITUTAS
LT · €176,875
UNIVERSIDAD DE GRANADA
ES · €242,500
UNIVERSITEIT TWENTE
NL · €340,938
DOTSOFT OLOKLIROMENES LISEIS TECHNOLOGIAS PLIROFORIKIS ANONIMI ETAIREIA
EL · €320,000
UNIVERSITA DEGLI STUDI DI TORINO
IT · €281,250
HOSPITAL SANT JOAN DE DEU
ES
FUNDATIA YOUTH CANCER EUROPE
RO · €156,250
UDG ALLIANCE
CH
VIDYASOFT SRL
IT · €338,750
KAUNO TECHNOLOGIJOS UNIVERSITETAS
LT · €215,000
C QUADRA SRL
IT · €322,250
UNIVERSIDAD DE LA IGLESIA DE DEUSTO ENTIDAD RELIGIOSA
ES · €312,500
SAMSUNG ELECTRONICS (UK) LIMITED
UK · €761,500
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
ES
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
IT · €548,750
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.